Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection
HCV相关啮齿动物肝炎病毒感染新小鼠模型的免疫、病毒适应和发病机制分析
基本信息
- 批准号:9332881
- 负责人:
- 金额:$ 70.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdaptive Immune SystemAffectAgeAlcoholsAnimal ModelAntigensAutomobile DrivingBasic ScienceCD8-Positive T-LymphocytesCellsCharacteristicsChronicChronic viral hepatitisCirrhosisComorbidityDevelopmentDiseaseEnvironmentFamilyFlavivirusFlow CytometryGenesGeneticGenetic DeterminismGenetic ScreeningHCV Animal ModelsHepacivirusHepaticHepatitis CHepatocyteHumanImmuneImmune EvasionImmune responseImmune systemImmunityImmunocompetentImmunologicsImmunologyInbred BALB C MiceInfectionInterferon Type IKineticsLaboratory miceLeadLightLiverLiver diseasesMHC Class I GenesMapsMedical ResearchModelingMolecular BiologyMouse StrainsMusNatural ImmunityObesityOutcomePan GenusPathogenesisPathologyPredispositionPrimary carcinoma of the liver cellsRNA Virus InfectionsRNA VirusesRattusRattus norvegicusResearchResistanceResolutionResourcesRodentRoleSignal TransductionSystems BiologyT-LymphocyteT-Lymphocyte EpitopesTissuesVaccinesVariantViralVirusVirus Diseasesadaptive immune responseadaptive immunityantiviral immunitybaseexhaustionin vivoinnovationinsightinterdisciplinary approachintrahepaticliver developmentliver injurymouse modelnovelpathogentooltranscriptome sequencingvaccination strategyvaccine developmentvirologyvirus host interactionvirus pathogenesis
项目摘要
Project summary
Many liver pathogens, like hepatitis C virus (HCV), have established mechanisms to subvert the host immune
response and to establish persistent infection. Dissecting these mechanisms and gaining insight into factors
that contribute to viral clearance versus chronicity in the liver is notoriously difficult. Access to human liver
tissue is limited. The only immunocompetent animal model of HCV infection, the chimpanzee, is no longer
readily available for research. However, we have recently succeeded in establishing the first immune-
competent mouse model of an HCV-related virus, Norway rat hepacivirus (NrHV). Our preliminary
characterization of this model revealed significant virological and immunological similarities with HCV infection
in humans. This advance now opens the opportunity to interrogate hepatic antiviral immunity, host-virus
interactions, viral adaptation, immune evasion strategies and pathogenesis of a hepatotropic virus at an
unprecedented level. In this proposal we plan to comprehensively analyze innate and adaptive intrahepatic
immune responses during hepacivirus infection in vivo and to define determinants of viral clearance. The
natural host of NrHV is the rat. In immune-competent mice NrHV is cleared after several weeks of infection.
Thus we plan to adapt this virus to the mouse, select for viral variants that can establish chronicity and
systematically analyze mechanisms of host-adaptation and immune evasion. Through NrHV infection of the
genetically diverse Collaborative Cross mouse colony at UNC, we will map the host genetic determinants of
clearance and persistence. We anticipate that combined approaches of viral adaptation to the murine host and
a host genetic screen will meet an important unmet need in establishing a robust model of virus-associated
liver disease. Taken together, our proposed research will use a diverse and multidisciplinary approach to shed
new light on hepatotropic virus infection in vivo. These insights should provide new strategies for vaccine
development or treatment of virus-associated liver disease.
项目摘要
许多肝炎病毒(HCV)等许多肝病病原体已经建立了颠覆宿主免疫的机制
反应并建立持续感染。解剖这些机制并深入了解因素
众所周知,这种导致病毒清除与肝脏中的慢性造成的贡献很困难。进入人肝
组织有限。 HCV感染的唯一免疫能力动物模型,黑猩猩,不再是
随时可用于研究。但是,我们最近成功建立了第一个免疫力
HCV相关病毒的合格小鼠模型,挪威大鼠肝病毒(NRHV)。我们的初步
该模型的表征揭示了与HCV感染显着的病毒学和免疫学相似性
在人类中。现在,这项进步打开了审问肝病病毒免疫的机会,宿主病毒
相互作用,病毒适应,免疫逃避策略和肝病病毒的发病机理
空前的水平。在此提案中,我们计划全面分析先天和适应性肝内
体内肝病毒感染期间的免疫反应并定义病毒清除的决定因素。这
NRHV的天然寄主是大鼠。在感染数周后,在免疫能力的小鼠中清除了NRHV。
因此,我们计划使该病毒适应小鼠,选择可以建立慢性和的病毒变体
系统地分析宿主适应和免疫逃避的机制。通过NRHV感染
在UNC的基因合作跨小鼠菌落中,我们将映射的宿主遗传决定因素
清除和持久性。我们预计病毒适应对鼠寄主的合并方法和
宿主遗传屏幕将满足建立与病毒相关的强大模型的重要未满足的需求
肝病。综上所述,我们拟议的研究将使用多种多样的多学科方法
在体内感染肝病感染的新光。这些见解应为疫苗提供新的策略
病毒相关肝病的发展或治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles M Rice其他文献
Charles M Rice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles M Rice', 18)}}的其他基金
Employing viruses to unravel the functional significance of the m5C epitranscriptome
利用病毒揭示 m5C 表观转录组的功能意义
- 批准号:
10638533 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
阐明 ADAR1 预防针对自身 RNA 的自身免疫的机制
- 批准号:
10667182 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
一次跟踪一个分子 SARS-CoV-2:体外和体内单细胞中冠状病毒复制动态和宿主反应的时空研究
- 批准号:
10446423 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
脑炎的清晰认识:用单细胞方法确定中枢神经系统黄病毒发病机制的基础
- 批准号:
10553697 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
一次跟踪一个分子 SARS-CoV-2:体外和体内单细胞中冠状病毒复制动态和宿主反应的时空研究
- 批准号:
10570297 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
Scientific Core: BSL3 Virology and Animal Models
科学核心:BSL3 病毒学和动物模型
- 批准号:
10327991 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
Scientific Core: BSL3 Virology and Animal Models
科学核心:BSL3 病毒学和动物模型
- 批准号:
10841239 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
脑炎的清晰认识:用单细胞方法确定中枢神经系统黄病毒发病机制的基础
- 批准号:
10446620 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
TMEM41B:具有抗病毒潜力的泛黄病毒和泛冠状病毒宿主因子
- 批准号:
10587597 - 财政年份:2022
- 资助金额:
$ 70.39万 - 项目类别:
相似海外基金
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Role of Interferon-Gamma / Interleukin-12 Axis in Metabolic Liver Disease
干扰素-γ/白介素-12 轴在代谢性肝病中的作用
- 批准号:
10735419 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Contribution of Vitamin D Deficiency to Pathological Progression in Models of Cerebral Hypoperfusion
维生素 D 缺乏对脑低灌注模型病理进展的影响
- 批准号:
10725358 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
纳米免疫药物靶向肿瘤微环境治疗神经胶质瘤
- 批准号:
10743942 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 70.39万 - 项目类别: